EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorUniversità Cattolica di Milano
About this trial
The main aim of the present process-outcome study is to evaluate the feasibility and the effects of an EMDR-IGTP-OTS group intervention on a sample of people with cancer, by using a process-outcome study design, with repeated measures.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
cancer diagnosis
PTSD (IES-R > 32)
Disqualifiers
receiving specialized trauma therapy
receiving current psychiatric pharmacological treatment, unless the dosage has been stable for at least 2 months prior to enrollment
Trial design
Design model
Single group
Treatments tested in this trial
EMDR-IGTP-OTS
BehavioralThe intervention follows the EMDR 8-phase protocol as indicated by Jarero et al. (2018). The group sessions use the IGTP-OTS (Integrative Group Treatment Protocol for Ongoing Traumatic Stress) to provide early stabilization.
Treatment groups
25 Participants
are divided into 1 treatment groupGroup A: EMDR Treatment GroupExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Impact of Event Scale-Revised (IES-R)
Impact of Event Scale-Revised range: The scale is composed by 22 items, each scored 0-4 (Min Score: 0; Max Score: 88). A higher score indicates a higher intensity of post-traumatic stress symptoms
Time frame
Baseline (T1) and Post-intervention (T2, approximately 1 month), Follow-up (T3, approximately 3 month)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Università Cattolica di Milano
Lead sponsor
ASST Santi Paolo e Carlo
Collaborator
Source ClinicalTrials.gov